Dolutegravir 50 mg , Tenofovir disoproxil Fumarate 300 mg and Lamivudine 300 mgTablets
dose combination antiretroviral medication formulated for the effective management of Human Immunodeficiency Virus type 1 (HIV-1) infection. Manufactured by Kureasia Pharma, this triple combination tablet provides a comprehensive and potent therapeutic approach that simplifies treatment regimens, enhances adherence, and supports sustained viral suppression in patients requiring lifelong HIV therapy. The formulation combines three active agents […]
Continue Reading